Abritis, A., A. Marcus, and I. Oransky. 2021. An “alarming” and “exceptionally high” rate of COVID-19 retractions? Accountability in Research 28(1): 58–59.
Agoramoorthy, G., M.J. Hsu and P. Shieh. 2020. Queries on the COVID‐19 quick publishing ethics. Bioethics 34(6): 633–634.
Article PubMed PubMed Central Google Scholar
Agrawal, G., R. Hermann, M. Møller, R. Poetes, and M. Steinmann. 2021. Fast-forward: Will the speed of COVID-19 vaccine development reset industry norms? McKinsey & Company, May 13. https://www.mckinsey.com/industries/life-sciences/our-insights/fast-forward-will-the-speed-of-covid-19-vaccine-development-reset-industry-norms. Accessed October 11, 2022.
Anderson, M.S., M.A. Shaw, N.H. Steneck, E. Konkle and T. Kamata. 2013. Research integrity and misconduct in the academic profession. Higher education: Handbook of Theory and Research: 217–261.
Angus, D.C., A.C. Gordon and H. Bauchner. 2021. Emerging lessons from COVID-19 for the US clinical research enterprise. JAMA 325(12): 1159–1161.
Article CAS PubMed Google Scholar
Bero, L., R. Lawrence, L. Leslie, et al. 2021. Cross-sectional study of preprints and final journal publications from COVID-19 studies: Discrepancies in results reporting and spin in interpretation. BMJ Open 11(7): e051821.
Bierer, B., S. White, J. Barnes, and L. Gelinas. 2020. Ethical challenges in clinical research during the COVID-19 pandemic. Journal of Bioethical Inquiry 17(4): 717–722.
Article CAS PubMed PubMed Central Google Scholar
Borgerson, K. 2017. Values in medical research. In The Routledge companion to philosophy of medicine, edited by M. Solomon, J. Simon, and H. Kincaid. Taylor & Francis.
Bramstedt, K.A. 2020. The carnage of substandard research during the COVID-19 pandemic: a call for quality. Journal of Medical Ethics 46(12): 803–807.
Bunnik, E.M., and J. Smids. 2021. Why exceptional public investment in the development of vaccines is justified for COVID-19, but not for other unmet medical needs. The American Journal of Bioethics 21(12): 22–25.
Article CAS PubMed Google Scholar
Butler, C., R. Hobbs, O. Gbinigie, et al. 2022. Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): Preliminary analysis from the United Kingdom randomised, controlled open-label, platform adaptive trial. SSRN 2022 Oct (preprint): https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4237902. Accessed July 26, 2023.
Capps, B. 2021. Where does open science lead us during a pandemic? A public good argument to prioritize rights in the open commons. Cambridge Quarterly of Healthcare Ethics 30(1): 11–24.
Caulfield, T., T. Bubela, J. Kimmelman, and V. Ravitsky. 2021. Let’s do better: Public representations of COVID-19 science. Facets 6(1): 403–423.
Churruca, K., K. Ludlow, N. Taylor, J.C. Long, S. Best and J. Braithwaite. 2019. The time has come: Embedded implementation research for health care improvement. Journal of Evaluation in Clinical Practice 25(3): 373–380.
Crooks, N., G. Donenberg, and A. Matthews. 2021. Ethics of research at the intersection of COVID-19 and black lives matter: A call to action. Journal of Medical Ethics 47(4): 205–207.
Daston, L., and P. Galison 2021. Objectivity. Princeton University Press.
Davey, M. 2020. Unreliable data: How doubt snowballed over COVID-19 drug research that swept the world. The Guardian, June 4. https://www.theguardian.com/world/2020/jun/04/unreliable-data-doubt-snowballed-covid-19-drug-research-surgisphere-coronavirus-hydroxychloroquine Accessed June 7, 2020.
Davey, M., S. Kirchgaessner, and S. Boseley. 2020a. Surgisphere: governments and WHO changed COVID-19 policy based on suspect data from tiny US company. The Guardian, June 4. https://www.theguardian.com/world/2020/jun/03/covid-19-surgisphere-who-world-health-organization-hydroxychloroquine. Accessed June 7, 2020.
Desmond, H. 2021. Expert communication and the self-defeating codes of scientific ethics. The American Journal of Bioethics 21(1): 24–26.
Di Girolamo, N., and R. Meursinge Reynders. 2020. Characteristics of scientific articles on COVID-19 published during the initial 3 months of the pandemic. Scientometrics 125(1): 795–812.
Article PubMed PubMed Central Google Scholar
Dinis-Oliveira, R.J. 2020. COVID-19 research: Pandemic versus “paperdemic,” integrity, values and risks of the “speed science.” Forensic Sciences Research 5(2): 174–187.
Article PubMed PubMed Central Google Scholar
Douglas, H. 2009. Science, policy, and the value-free ideal. University of Pittsburgh Press.
Dove, E.S., and V. Özdemir. 2015. What role for law, human rights, and bioethics in an age of big data, consortia science, and consortia ethics? The importance of trustworthiness. Laws 4(3): 515–540.
Dunn, D., R. Gilson, S. McCormack, and L. McCoy. 2022. Dose of approved COVID-19 vaccines is based on weak evidence: a review of early-phase, dose-finding trials. medRxiv: https://doi.org/10.1101/2022.09.20.22276701. Accessed July 26, 2023.
El-Menyar, A., A. Mekkodathil, M. Asim, et al. 2021. Publications and retracted articles of COVID-19 pharmacotherapy-related research: A systematic review. Science Progress 104(2): 00368504211016936.
Article CAS PubMed PubMed Central Google Scholar
Faust, A., A. Sierawska, K. Krüger, A. Wisgalla, J. Hasford, and D. Strech. 2021. Challenges and proposed solutions in making clinical research on COVID-19 ethical: A status quo analysis across German research ethics committees. BMC Medical Ethics 22: 96.
Article PubMed PubMed Central Google Scholar
Gautret, P., J.-C. Lagier, P. Parola, et al. 2020. Hydroxychloroquine and azithromycin as a treatment of COVID-19: Results of an open-label non-randomized clinical trial. International Journal of Antimicrobial Agents 56(1): 105949.
Article CAS PubMed PubMed Central Google Scholar
Glasziou, P.P., S. Sanders, and T. Hoffmann. 2020. Waste in COVID-19 research. BMJ 369: m1847.
Goldenberg, M. 2021. Vaccine hesitancy: Public trust, expertise, and the war on science. University of Pittsburgh Press.
Grady, C. 2021. Another cautionary lesson from COVID research. The American Journal of Bioethics 21(12): 36–39.
Grein, J., N. Ohmagari, D. Shin, et al. 2020. Compassionate use of remdesivir for patients with severe COVID-19. New England Journal of Medicine 382(24): 2327–2336.
Article CAS PubMed Google Scholar
Hafner, M., E. Yerushalmi, C. Fays, E. Dufresne, and C. Van Stolk. 2020. COVID-19 and the cost of vaccine nationalism. United Kingdom: RAND Cambridge.
Herper, M., and E. Riglin. 2020. Data show panic and disorganization dominate the study of COVID-19 drugs. STAT, July 6. https://www.statnews.com/2020/07/06/data-show-panic-and-disorganization-dominate-the-study-of-covid-19-drugs/. Accessed October 25, 2022.
Horbach, S.P. 2020. Pandemic publishing: Medical journals strongly speed up their publication process for COVID-19. Quantitative Science Studies 1(3): 1056–1067.
Hornsey, M.J., J. Lobera, and C. Díaz-Catalán. 2020. Vaccine hesitancy is strongly associated with distrust of conventional medicine, and only weakly associated with trust in alternative medicine. Social Science & Medicine 255: 113019.
InterAcademy Partnership (IAP). 2016. Doing global science: A guide to responsible conduct in the global research enterprise. iThenticate, July 8. https://www.ithenticate.com/plagiarism-detection-blog/interacademy-partnership-releases-revised-guide-for-responsible-research. Accessed October 22, 2022.
Jamrozik, E., G.S. Heriot, and M.J. Selgelid. 2020. Coronavirus human infection challenge studies: Assessing potential benefits and risks. Journal of Bioethical Inquiry 17(4): 709–715.
Article PubMed PubMed Central Google Scholar
Johansson, M.A., and D. Saderi. 2020. Open peer-review platform for COVID-19 preprints. Nature 579(7797): 29–30.
Article CAS PubMed Google Scholar
Johnson, K.E., C. Tachibana, G.D. Coronado, et al. 2014. A guide to research partnerships for pragmatic clinical trials. BMJ 349: g6826.
Article PubMed PubMed Central Google Scholar
Kandel, E. 2021. There is life after the Nobel Prize. Columbia University Press.
Kesselheim, A.S., and J. Avorn. 2017. New “21st century cures” legislation: Speed and ease vs science. JAMA 317(6): 581–582.
Kessler, R., and R.E. Glasgow. 2011. A proposal to speed translation of healthcare research into practice: Dramatic change is needed. American Journal of Preventive Medicine 40(6): 637–644.
Kitcher, P. 2001. Science, truth, and democracy. New York: Oxford University Press.
Kretser, A., D. Murphy, S. Bertuzzi, et al. 2019. Scientific integrity principles and best practices: Recommendations from a scientific integrity consortium. Science and Engineering Ethics 25(2): 327-355.
Article PubMed PubMed Central Google Scholar
Ledford, H. 2020. Chloroquine hype is derailing the search for coronavirus treatments. Nature 580(7805): 573–574.
Article CAS PubMed Google Scholar
Ledford, H., R. van Noorden. 2020. High-profile coronavirus retractions raise concerns about data oversight. Nature News, June 5. https://www.nature.com/articles/d41586-020-01695-w. Accessed June 7, 2020.
Lee, K., and N. Eyal. 2021. COVID-19 controlled human infection studies: Worries about local community impact and demands for local engagement. Journal of Medical Ethics 47(8): 539–542.
Lenzer, J. 2020. COVID-19: Should vaccine trials be unblinded? BMJ 371: m4956.
Lipworth, W., M. Gentgall, I. Kerridge, and C. Stewart. 2020. Science at warp speed: Medical research, publication and translation during the COVID-19 pandemic. Journal of Bioethical Inquiry 17: 555–561.
留言 (0)